Manufacturing Considerations in Drug Development

Thursday, November 30, 10-12 pm: Weill Cornell Medicine BioVenture eLab, a part of Weill Cornell Medicine Enterprise Innovation, invites WCM faculty and trainees working in drug development to join an educational program focused on designing an R&D and manufacturing plan for your innovation.

Featuring Catalent Pharma Solutions, a renowned global CDMO that partners with pharma and biotech companies to accelerate and lead development, the program will include two presentations – one focused on biologics and another on small molecules. Following the presentations, the Catalent representatives will be available to meet 1:1 with you and your team to offer tailored mentoring for your specific project.

Presentations: 10-12 pm (Hybrid)

– Biologics Presentation: Strategic Considerations in Biologics CMC Development to Ensure Successful Path to IND

– Small Molecules Presentation: Streamlining Formulation and Delivery of Small Molecules in Early Development

– 1:1 Meetings: 12:30-5pm (In-person) – You need to register for the program in order to schedule a 1:1 appointment.

This is a hybrid program where the presentation portion will take place at BioVenture eLab, 1157 York Ave, and will include a Zoom option. However, please note that 1:1 meetings will be in-person only and will be held at Belfer Research Building (413 E 69th St) from 12:30-5 pm.

Register now